Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
164
datasets available to search
ShareScore release 0.9.0
Dataset results
164 results for “relative position”
Effects of Body Position and Recruiting Maneuver on Lung Aeration Assessed Through Ultrasound in Patients Intubated for Acute Respiratory Failure Related to Novel Coronavirus 19 Disease
ClinicalTrials.gov study NCT05209477. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Relation Between Position of the Uterus (Anteversion or Retroversion Flexion) and Degree of Cesarean Scar Niche
ClinicalTrials.gov study NCT06475924. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chromosome positioning and the clustering of functionally related loci in yeast is driven by chromosomal interactions
GEO Series GSE33018. Saccharomyces cerevisiae. 2 samples. Type: Other.
Data from: Positive and negative incentive contrasts lead to relative value perception in ants
Open the record for dataset details and reuse information.
Secreted frizzled related protein 3 (SFRP3) is required for tumorigenesis of PAX3-FOXO1-positive alveolar rhabdomyosarcoma
GEO Series GSE67999. Homo sapiens. 12 samples. Type: Expression profiling by array.
The nuclear actin-related protein Arp6 contributes to the radial positioning of chromosome territories.
GEO Series GSE14220. Gallus gallus. 4 samples. Type: Expression profiling by array.
c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer [expression profiling]
GEO Series GSE102367. Homo sapiens. 18 samples. Type: Expression profiling by array.
CTCF binding landscape is established by the epigenetic status of the nucleosome, well-positioned relative to CTCF motif orientation
GEO Series GSE277826. Mus musculus. 30 samples. Type: Methylation profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Abbreviations: ILK: indigenous and local knowledge; IPLCs: indigenous peoples and local communities; NBSAPs: national biodiversity strategies and action plans. a Strategic Plan for Biodiversity 2011–2020. Figure 6. Summary of progress towards the Aichi Targets. Scores are based on quantitative analysis of indicators, a systematic review of the literature, fifth National Reports to the CBD, and available information on countries' stated intentions to implement additional actions by 2020. Progress towards target elements is scored as "Good" (substantial positive trends at a global scale relating to in Summary for policymakers of the global assessment report on biodiversity and ecosystem services - unedited advance version
Abbreviations: ILK: indigenous and local knowledge; IPLCs: indigenous peoples and local communities; NBSAPs: national biodiversity strategies and action plans. a Strategic Plan for Biodiversity 2011–2020. Figure 6. Summary of progress towards the Aichi Targets. Scores are based on quantitative analysis of indicators, a systematic review of the literature, fifth National Reports to the CBD, and available information on countries' stated intentions to implement additional actions by 2020. Progress towards target elements is scored as "Good" (substantial positive trends at a global scale relating to
Figure 5 in Phylogenetic position of the poorly known montane cascade frog Amolops monticola (Ranidae) and description of a new closely related species from Northeast India
Figure 5. Topotype of Amolops monticola in preservation, an adult female, BNHS 6120: (a) dorsal view; (b) ventral view; (c) lateral view of head; (d) ventral view of hand; (e) ventral view of foot; (f) schematic illustration of webbing on foot.
A Brief Affirmation Intervention on HIV-related Distress and Positive Living in Lesotho
ClinicalTrials.gov study NCT03762187. IPD Sharing: NO. Countries: 0. Publications: 0.
The Favorable Impact of HBcAb Positive Grafts on Liver Transplantation for HBV-related HCC
ClinicalTrials.gov study NCT06787534. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women
ClinicalTrials.gov study NCT01311752. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT02762448. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Estrogen-induced CircRNA, CircPGR, Functions as a CeRNA to Promote Estrogen Receptor-positive Breast Cancer Progression by Regulating Cell Cycle-related Genes
GEO Series GSE145729. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing.
From gene networks to network motif dynamics: how the presense of positive feed-back and -forward loops between PERIANTHIA, WUSCHEL-RELATED HOMEOBOX5 and GRF-INTERACTING FACTOR 1 modulates gene expres
GEO Series GSE118102. Arabidopsis thaliana. 13 samples. Type: Expression profiling by high throughput sequencing.
Dataset related to article "Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab."
<p>This record contains data related to article "Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab"</p> <p> </p> <p><strong>Background: </strong> Few data are available about real-life cardiotoxicity associated with s.c. versus i.v. trastuzumab treatment of early-stage, HER2-positive breast cancer, and little is known about its predisposing factors.</p> <p><strong>Patients and methods: </strong> We retrospectively reviewed data of 363 adult patients treated with adjuvant trastuzumab for HER2-positive breast cancer. Univariate statistical analysis was performed, and a multivariable logistic model was developed to identify independent risk factors of cardiac toxicity.</p> <p><strong>Results: </strong> Within 5 years, the overall incidence of events meeting our criteria was 11.8%, and an early discontinuation of trastuzumab was recorded in 20 patients (5.5%). No cases of congestive heart failure occurred, neither multiple events per patient were observed. A total of 184 patients received i.v. and 179 received s.c. trastuzumab. Compared with the s.c. formulation, a higher cardiotoxicity rate for the i.v. administration (15.2% vs 8.4%) was found, and particularly in those patients with cardiovascular risk factors (19.3% vs 8.7%), at the univariate and multivariate analyses. Although more patients with prior anthracycline-based chemotherapy experienced cardiac events, the association of this therapy with cardiac events was not significant. The incidence of cardiac events was not influenced by anthropometric data (e.g. body mass index) or a diagnosis of diabetes mellitus. 5-year event-free survival was 91.7% in the overall population; event-free survival rates were similar between the s.c. and the i.v. groups.</p> <p><strong>Conclusion: </strong> Our study shows a more favorable safety profile of s.c. versus i.v trastuzumab administration. The use of s.c. trastuzumab could be advisable in at-risk patients.</p> <p> </p>
Dataset related to article "Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment"
<p>Abstract</p><p>Total marrow (lymph node) irradiation (TMI/TMLI) delivery requires more time than standard radiotherapy treatments. The patient's extremities, through the joints, can experience large movements. The reproducibility of TMI/TMLI patients' extremities was evaluated to find the best positioning and reduce unwanted movements. Eighty TMI/TMLI patients were selected (2013-2022). During treatment, a cone-beam computed tomography (CBCT) was performed for each isocenter to reposition the patient. CBCT-CT pairs were evaluated considering: (i) online vector shift (OVS) that matched the two series; (ii) residual vector shift (RVS) to reposition the patient's extremities; (iii) qualitative agreement (range 1-5). Patients were subdivided into (i) arms either leaning on the frame or above the body; (ii) with or without a personal cushion for foot positioning. The Mann-Whitney test was considered (p < 0.05 significant). Six-hundred-twenty-nine CBCTs were analyzed. The median OVS was 4.0 mm, with only 1.6% of cases ranked < 3, and 24% of RVS > 10 mm. Arms leaning on the frame had significantly smaller RVS than above the body (median: 8.0 mm/6.0 mm, p < 0.05). Using a personal cushion for the feet significantly improved the RVS than without cushions (median: 8.5 mm/1.8 mm, p < 0.01). The role and experience of the radiotherapy team are fundamental to optimizing the TMI/TMLI patient setup.</p><p> </p>
Dataset related to article "Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node-positive head and neck cancer"
<p><strong> Abstract</strong></p><p>Background: Prediction of survival and radiation therapy response is challenging in head and neck cancer with metastatic lymph nodes (LNs). Here we developed novel radiomics- and clinical-based predictive models.</p><p>Methods: Volumes of interest of LNs were employed for radiomic features extraction. Radiomic and clinical features were investigated for their predictive value relatively to locoregional failure (LRF), progression-free survival (PFS), and overall survival (OS) and used to build multivariate models.</p><p>Results: Hundred and six subjects were suitable for final analysis. Univariate analysis identified two radiomic features significantly predictive for LRF, and five radiomic features plus two clinical features significantly predictive for both PFS and OS. The area under the curve of receiver operating characteristic curve combining clinical and radiomic predictors for PFS and OS resulted 0.71 (95%CI: 0.60-0.83) and 0.77 (95%CI: 0.64-0.89).</p><p>Conclusions: Radiomic and clinical features resulted to be independent predictive factors, but external independent validation is mandatory to support these findin</p>
Dataset related to article "Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy"
<p>This record contains raw data related to article "Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy"</p><p>Abstract</p><p><strong>Background: </strong>Sentinel lymph node biopsy (SLNB) has emerged as the standard procedure to replace axillary lymph node dissection (ALND) in breast cancer (BC) patients undergoing neo-adjuvant chemotherapy (NAC). SLNB is accepted in clinically node-negative (cN0) patients; however, its role in clinically node-positive (cN+) patients is debatable.</p><p><strong>Methods: </strong>We performed a retrospective analysis of BC patients undergoing NAC and SLNB. Our aim was to evaluate the clinical significance of SLNB in the setting of NAC. This was accomplished by comparing the characteristics and oncological outcomes between cN0 and cN+ patients prior to NAC and type of axillary surgery.</p><p><strong>Results: </strong>A total of 291 patients were included in the analysis: 131 were cN0 and 160 were cN+ who became ycN0 after NAC. At a median follow-up of 43 months, axillary recurrence occurred in three cN0 (2.3%) and two cN+ (1.3%) patients. However, there were no statistically significant differences in oncological outcomes (disease-free survival, distant disease-free survival, overall survival, and breast-cancer-specific survival) between cN0 and cN+ patients nor between patients treated with SLNB only or ALND.</p><p><strong>Conclusions: </strong>SLNB in the setting of NAC is an acceptable procedure with a general good prognosis and low axillary failure rates for both cN0 and cN+ patients.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.